HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at Roth Capital raised their FY2025 earnings estimates for shares of HIVE Blockchain Technologies in a research note issued to investors on Monday, January 6th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of ($0.54) for the year, up from their prior estimate of ($0.55). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.10) EPS, Q3 2026 earnings at ($0.04) EPS, FY2027 earnings at $0.23 EPS and FY2028 earnings at ($0.10) EPS.
Several other brokerages have also commented on HIV. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- The Role Economic Reports Play in a Successful Investment Strategy
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Stock Average Calculator
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Investing In Preferred Stock vs. Common Stock
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
